文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

免疫功能低下儿童的疫苗接种——给医生的概述

Vaccination of immune compromised children-an overview for physicians.

作者信息

Pittet Laure F, Posfay-Barbe Klara M

机构信息

Infectious Diseases Unit, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Unit of Pediatric Infectious Diseases, Division of General Pediatrics, Department of Pediatrics, Gynecology & Obstetrics, Children's Hospital, University Hospitals of Geneva, 6 Rue Willy Donzé, 1211, Geneva, Switzerland.

出版信息

Eur J Pediatr. 2021 Jul;180(7):2035-2047. doi: 10.1007/s00431-021-03997-1. Epub 2021 Mar 5.


DOI:10.1007/s00431-021-03997-1
PMID:33665677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8195953/
Abstract

Immune compromised children are threatened by a higher risk of infections; some of these are preventable by vaccination. Primary care physicians play a fundamental role in optimising vaccination status. In this narrative review, we present the evidence on vaccine safety and immunogenicity in immune compromised children and discuss in which conditions live-attenuated vaccines can possibly be used. Vaccination schedules differ in some of these conditions, including the use of vaccines with higher antigenic contents (e.g. high-dose hepatitis B vaccine), additional vaccine doses (e.g. 2-dose schedule meningococcal vaccine), more frequent booster doses (e.g. life-long pneumococcal vaccine booster), supplementary vaccines (e.g. meningococcal B vaccine) and use of vaccines beyond the age of usual recommendation (e.g. Haemophilus influenza type b vaccine after 5 years of age). Serological monitoring is a useful tool for customizing vaccination schedule in immune compromised children, confirming adequate vaccine response and documenting seroprotection (especially against measles and varicella). Finally, verification of vaccination status of all household members can prevent them being vector of transmission of an infection to the immune compromised children. Conclusion: Intensified information strategies are needed to improve trust, rectify perceived risks and improve vaccine acceptability; primary physicians can play a critical role in the latter. What is Known: • Physician's awareness is key to success, since it repeatedly correlates with higher vaccination rates What is New: • The vaccination status of immunocompromised children is rarely up-to-date • Knowing the latest vaccine recommendations is challenging, as they differ for each medical condition and change periodically • This review summarises the vaccine recommendations for children with compromised immune systems and highlights how paediatricians play a key role in coordinating their application.

摘要

免疫功能低下的儿童面临着更高的感染风险;其中一些感染可通过接种疫苗预防。初级保健医生在优化疫苗接种状况方面发挥着重要作用。在这篇叙述性综述中,我们展示了免疫功能低下儿童疫苗安全性和免疫原性的证据,并讨论了在哪些情况下可以使用减毒活疫苗。在其中一些情况下,疫苗接种计划有所不同,包括使用抗原含量更高的疫苗(如高剂量乙肝疫苗)、额外的疫苗剂量(如两剂次的脑膜炎球菌疫苗接种计划)、更频繁的加强剂量(如终身肺炎球菌疫苗加强针)、补充疫苗(如B型脑膜炎球菌疫苗)以及在通常推荐年龄之后使用疫苗(如5岁后接种b型流感嗜血杆菌疫苗)。血清学监测是为免疫功能低下儿童定制疫苗接种计划、确认足够的疫苗反应以及记录血清保护(特别是针对麻疹和水痘)的有用工具。最后,核查所有家庭成员的疫苗接种状况可防止他们成为将感染传播给免疫功能低下儿童的载体。结论:需要加强信息策略以提高信任度、纠正感知到的风险并提高疫苗可接受性;初级医生在后者方面可发挥关键作用。已知信息:• 医生的意识是成功的关键,因为它反复与更高的疫苗接种率相关 新信息:• 免疫功能低下儿童的疫苗接种状况很少是最新的 • 了解最新的疫苗推荐具有挑战性,因为每种医疗状况的推荐都不同且会定期变化 • 本综述总结了免疫功能低下儿童的疫苗推荐,并强调了儿科医生在协调疫苗应用方面如何发挥关键作用

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/8195953/2de28947b393/431_2021_3997_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/8195953/a7b59d304e01/431_2021_3997_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/8195953/2de28947b393/431_2021_3997_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/8195953/a7b59d304e01/431_2021_3997_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/8195953/2de28947b393/431_2021_3997_Fig2_HTML.jpg

相似文献

[1]
Vaccination of immune compromised children-an overview for physicians.

Eur J Pediatr. 2021-7

[2]
Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine.

Pediatr Infect Dis J. 2005-1

[3]
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).

Vaccine. 2017-6-27

[4]
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.

Pediatrics. 2005-11

[5]
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.

Commun Dis Intell Q Rep. 2013-12-31

[6]
Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

Pediatrics. 2001-12

[7]
Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.

Pediatr Infect Dis J. 2006-4

[8]
Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).

BioDrugs. 2010-10-1

[9]
Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.

MMWR Recomm Rep. 1996-11-22

[10]
[Immunogenicity and reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib vaccines coadministered with 7-valent pneumococcal conjugate vaccine as primary vaccination and booster in healthy infants, according to the French vaccination calendar].

Arch Pediatr. 2008-3

引用本文的文献

[1]
HPV Infection in Children and Adolescents-A Comprehensive Review.

J Clin Med. 2025-4-2

[2]
Immunocyte phenotypes and childhood disease susceptibility: insights from bidirectional Mendelian randomization and implications for immunomodulatory therapies.

Naunyn Schmiedebergs Arch Pharmacol. 2025-4-3

[3]
Vaccination Coverage and Attitudes in Children and Adults on Biologic Therapies: Cocooning Strategies, Undervaccination Factors and Predictors of Favorable Attitudes.

Vaccines (Basel). 2025-2-1

[4]
Global research landscape of health care-associated infections among immunocompromised people before and after the start of the COVID-19 pandemic.

Infect Med (Beijing). 2024-8-10

[5]
Native Joint Septic Arthritis.

Antibiotics (Basel). 2024-6-27

[6]
IgG antibody response to pneumococcal-conjugated vaccine (Prevenar®13) in children with immunodeficiency disorders.

Med Microbiol Immunol. 2023-2

[7]
Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients.

Cancer Manag Res. 2021-12-1

[8]
Uptake of Vaccinations among Children with Chronic Diseases Is Affected by Knowledge Gaps and Implementation Challenges in Italy.

Vaccines (Basel). 2021-10-20

[9]
Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.

Lancet Child Adolesc Health. 2022-1

本文引用的文献

[1]
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2020.

MMWR Morb Mortal Wkly Rep. 2020-2-7

[2]
High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients.

Am J Kidney Dis. 2020-3

[3]
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.

Expert Rev Anti Infect Ther. 2020-2

[4]
Varicella-zoster virus post-exposure management and prophylaxis: A review.

Prev Med Rep. 2019-11-6

[5]
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative review.

Intensive Care Med. 2019-11-26

[6]
Under-immunization of pediatric transplant recipients: a call to action for the pediatric community.

Pediatr Res. 2020-1

[7]
Expert consensus on palivizumab use for respiratory syncytial virus in developed countries.

Paediatr Respir Rev. 2018-12-18

[8]
Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs.

JAMA Pediatr. 2019-3-1

[9]
The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

Expert Rev Vaccines. 2018-12-27

[10]
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

J Cutan Med Surg. 2019

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索